Consolidated Statements of Cash Flows (unaudited) - USD ($)	6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (10,266,131)	$ (13,050,033)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	152,620	172,060
Decrease in right-of-use asset	179,677	174,098
Unrealized foreign currency transaction loss (gain)	(12,000)	146,947
Stock-based compensation	697,978	940,307
Change in fair value of liability classified warrants	0	7,391,591
Gain on sale of Vyleesi	2,500,000	7,823,482
Changes in operating assets and liabilities:
Accounts receivable	0	569,597
Prepaid expenses and other assets	(10,841)	1,047,164
Inventories	0	(1,154,355)
Accounts payable	2,616,304	(2,710,051)
Accrued expenses	(2,534,346)	(896,812)
Operating lease liabilities	(186,580)	(176,913)
Other liabilities	0	(1,012,197)
Net cash used in operating activities	(11,863,319)	(16,382,079)
CASH FLOWS FROM INVESTING ACTIVITIES:
Maturity of marketable securities	0	2,992,890
Proceeds from sale of Vyleesi	2,500,000	9,500,000
Purchases of property and equipment	0	(37,615)
Net cash provided by investing activities	2,500,000	12,455,275
CASH FLOWS FROM FINANCING ACTIVITIES:
Payment of withholding taxes related to restricted stock units	(99,482)	(56,401)
Proceeds from the sale of common stock and warrants, net	0	5,531,266
Payment of finance lease obligations	(46,014)	(52,494)
Proceeds from exercise of warrants	3,398,023	103
Net cash (used in) provided by financing activities	3,252,527	5,422,474
NET DECREASE IN CASH AND CASH EQUIVALENTS	(6,110,792)	1,495,670
CASH AND CASH EQUIVALENTS, beginning of period	9,527,396	7,989,582
CASH AND CASH EQUIVALENTS, end of period	3,416,604	9,485,252
SUPPLEMENTAL CASH FLOW INFORMATION:
Cash paid for interest	9,743	10,882
Conversion of liability classified warrants upon warrant exercise	$ 0	$ 2,389,903